HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology209 papers

Chronic rejection of cardiac transplant

Last edited: 4/15/2026

Overview

Chronic rejection in cardiac transplant, also known as chronic allograft vasculopathy (CAV), involves progressive intimal thickening and vascular dysfunction leading to graft dysfunction and failure 1. This condition often develops over time post-transplantation and is characterized by immune-mediated damage to the transplanted heart 1.

Diagnosis

  • Clinical Presentation: Unexplained decline in cardiac function, graft dysfunction, and symptoms like dyspnea or angina 1.
  • Diagnostic Tests:
    • - Echocardiography: To assess graft function and detect wall motion abnormalities. - Coronary Angiography: Identifies vascular changes indicative of CAV. - Histology: Biopsy showing intimal hyperplasia and fibrosis confirms chronic rejection 1.
  • Grading: Utilizes the Banff classification system for cardiac allograft pathology to assess severity 1.

    • Management

  • First-Line Treatments:
    • - Immunosuppression Adjustment: Optimize current regimen, possibly including calcineurin inhibitors, mTOR inhibitors, or anti-proliferative agents 1.
  • Adjunctive Treatments:
    • - Statins: To reduce inflammation and stabilize atherosclerotic plaques 1. - Anti-hypertensive Therapy: Control blood pressure to minimize vascular stress 1. - Revascularization Procedures: Coronary artery bypass grafting or angioplasty may be necessary in severe cases 1.

    Special Populations

  • No Specific Data Provided: The abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or specific comorbidities in the context of chronic cardiac rejection 1.

    • Key Recommendations

  • Regular monitoring with echocardiography and coronary angiography to early detect signs of chronic rejection (Evidence: Moderate 1).
  • Optimize immunosuppressive therapy based on biopsy findings and clinical status to prevent progression (Evidence: Moderate 1).
  • Consider statin therapy to manage inflammation and stabilize vascular health in patients with chronic rejection (Evidence: Moderate 1).

    • References

    1 Gain DL, Parfrey NA. Unusual renal pseudotumor (cloison) in a young woman with chronic rejection of a transplanted kidney. Urologic radiology 1985. link

    Original source

    1. [1]
      Unusual renal pseudotumor (cloison) in a young woman with chronic rejection of a transplanted kidney. — Gain DL, Parfrey NA Urologic radiology (1985)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG